To date, some researches have demonstrated that IFN-γ can inhibit tumor angiogenesis by downregulating integrin αVβ3, Dll4, Dll1, and vascular endothelial growth factor A (VEGF-A) (23–28). The gene discussed is IFNG; the disease is neoplasm.